Published in Klin Lab Diagn on November 01, 2015
Fgf-10 is required for both limb and lung development and exhibits striking functional similarity to Drosophila branchless. Genes Dev (1998) 4.58
Long-term impaired neutrophil migration in mice overexpressing human interleukin-8. J Clin Invest (1994) 1.51
Stimulation of all epithelial elements during skin regeneration by keratinocyte growth factor. J Exp Med (1994) 1.32
Monoclonal antibodies specific for canine CD4 and CD8 define functional T-lymphocyte subsets and high-density expression of CD4 by canine neutrophils. Tissue Antigens (1992) 1.22
Pulmonary malformation in transgenic mice expressing human keratinocyte growth factor in the lung. Proc Natl Acad Sci U S A (1995) 1.16
Anemia and perinatal death result from loss of the murine ecotropic retrovirus receptor mCAT-1. Genes Dev (1997) 1.10
FGF-18, a novel member of the fibroblast growth factor family, stimulates hepatic and intestinal proliferation. Mol Cell Biol (1998) 1.05
Systemically and topically administered leptin both accelerate wound healing in diabetic ob/ob mice. Endocrinology (2000) 1.02
Keratinocyte growth factor causes proliferation of urothelium in vivo. J Urol (1995) 1.02
CD4+CD45RBHi T cell transfer induced colitis in mice is accompanied by osteopenia which is treatable with recombinant human osteoprotegerin. Gut (2005) 1.00
A humanized monoclonal antibody targeting the β7 integrin selectively blocks intestinal homing of T lymphocytes. Br J Pharmacol (2011) 0.94
Dynamics of immunofluorescence and infectivity of parainfluenza 3 virus in susceptible cells. Acta Virol (1967) 0.93
[Analysis of pandemic influenza in Russia as a part of the global process based on data of an influenza monitoring reference center]. Zh Mikrobiol Epidemiol Immunobiol (2011) 0.83
Combined treatment of acute EAE in Lewis rats with TNF-binding protein and interleukin-1 receptor antagonist. Exp Neurol (1998) 0.83
Canine leukocyte integrins: characterization of a CD18 homologue. Tissue Antigens (1990) 0.83
[The 2009 pandemic influenza in Russia. I. Diagnosis and molecular biological characteristics of the virus]. Vopr Virusol (2011) 0.81
[Etiological characteristics of the influenza epidemics of 2006-2009 in the Russian Federation (according to the data of the Research Institute of Influenza, North-Western Branch, Russian Academy of Medical Sciences)]. Vopr Virusol (2010) 0.81
The efficacy of cell therapy in the treatment of patients with trophic venous ulcers of the lower limbs. Angiol Sosud Khir (2007) 0.79
The tsA58 simian virus 40 large tumor antigen disrupts megakaryocyte differentiation in transgenic mice. Proc Natl Acad Sci U S A (1994) 0.79
[Molecular characteristic of influenza virus A H5N1 Strains isolated from poultry in Kurgan Region in 2005]. Mol Biol (Mosk) (2008) 0.78
Investigation of epidermotropism in canine mycosis fungoides: expression of intercellular adhesion molecule-1 (ICAM-1) and beta-2 integrins. Arch Dermatol Res (1995) 0.78
[Study of the antiviral activity of Russian anti-influenza agents in cell culture and animal models]. Vopr Virusol (2010) 0.78
[The use of halotherapy for the rehabilitation of patients with acute bronchitis and a protracted and recurrent course]. Vopr Kurortol Fizioter Lech Fiz Kult (1995) 0.77
[Experimental investigation of Ingavirin antiviral activity against human parainfluenza virus]. Antibiot Khimioter (2010) 0.76
[Influence of rimantadine, ribavirine and triazavirine on influenza A virus replication in human monolayer and lymphoblastoid cell lines]. Antibiot Khimioter (2011) 0.75
[Population heterogeneity of modern influenza B virus strains]. Mikrobiol Zh (1980) 0.75
[Ultrastructural changes in the cells of human embryo lung fibroblasts in the reproduction of the coronavirus HCoV/SPb/01/03]. Vopr Virusol (2006) 0.75
[Isolation and characteristics of anti-adenovirus monoclonal antibodies in immunoenzyme and immunofluorescent reactions]. Vopr Virusol (2001) 0.75
[Determination of the diagnostic parameters of domestic immunoenzyme test systems versus foreign analogues in the detection of serum rubella virus antibodies]. Klin Lab Diagn (2010) 0.75
[New monoclonal kits for the diagnosis of the adenoviral infection]. Vopr Virusol (2014) 0.75
[IMPACT OF VARIOUS MULTIPLICITY OF INFECTION OF INFLUENZA A VIRUS ON PROLIFERATION AND APOPTOSIS INDUCTION IN CULTURED CELL LINES OF LYMPHOCYTIC AND MONOCYTIC ORIGIN (JURKAT, NC-37, THP-1 AND U-937)]. Tsitologiia (2015) 0.75
[Indices of the humoral response to respiratory syncytial virus infection in children with acute bronchitis]. Lab Delo (1991) 0.75
[Development of influenza surveillance in Russia in the system of the WHO national influenza center]. Vopr Virusol (2013) 0.75
[Influence of cultivation conditions on bacterial DNA content and bacterial membrane permeability]. Vestn Ross Akad Med Nauk (2005) 0.75
[Pathogenic aspects of influenza during the epidemics caused by A/H1N1v virus in 2009-2010 according autopsy data]. Arkh Patol (2012) 0.75
[Influenza A virus antigens in children with congenital pathology of central nervous system]. Vestn Ross Akad Med Nauk (1994) 0.75
[Characterization of cold-adapted influenza strain A/HongKong/1/68/162/35 as a potential donor of attenuation and high reproduction]. Vopr Virusol (2013) 0.75
[Rapid preparation of inhibitor-resistant clones of the influenza A viruses for diagnostic purposes]. Tr Inst Im Pastera (1982) 0.75
[Pandemic influenza 2009 in Russia. Characteristics of the isolation and biological properties of viruses]. Vopr Virusol (2011) 0.75
[The age-related specificity of site-oriented immunity in respiratory-syncytial virus infection]. Vopr Virusol (2004) 0.75
[Study of the harmlessness, antigenicity and immunogenic activity of live antiparainfluenza vaccine]. Vestn Akad Med Nauk SSSR (1970) 0.75
[Cell therapy in treatment of trophic ulcers of lower extremities]. Vestn Khir Im I I Grek (2006) 0.75
[Comparative study of the differential susceptibility of different cell lines to pandemic H1N1v influenza viruses and avian influenza, swine influenza, and human influenza viruses]. Vopr Virusol (2012) 0.75
[Characteristics of monoclonal antibodies to RS virus in immunoenzyme and immunofluorescence techniques]. Vestn Ross Akad Med Nauk (1995) 0.75
[Use of immunoenzyme analysis for detecting antibodies to respiratory syncytial virus with the aid of a conjugate of staphylococcal protein A with peroxidase]. Vopr Virusol (1991) 0.75
[Humoral antiviral immunity in children with hematologic neoplasms]. Vopr Virusol (1995) 0.75
Comparative studies on influenza B virus. II. The effect of host cells on biological properties and polypeptide composition. Acta Virol (1983) 0.75
Improved methods of influenza virus propagation. II. Characteristics of cell culture and allantoic virus preparations. Acta Virol (1977) 0.75
[The application of synthetic peptides to characterize the site-directed antiviral humoral immune response in patients with respiratory syncytial viral infection]. Klin Lab Diagn (2012) 0.75
[Analysis of etiology of influenza-like morbidity and monitoring influenza epidemic of 1998-1999 by laboratory diagnosis methods]. Vestn Ross Akad Med Nauk (2001) 0.75
[Influenza vaccine stimulation of antibodies to different variants of influenza A virus]. Vopr Virusol (1985) 0.75
[Genetic predisposition to latent influenza A virus in children with blood type B(III) as a possible cause of new epidemiologic strains in the countries of South-Eastern Asia]. Vestn Ross Akad Med Nauk (1994) 0.75
[Role of cellular cytoskeleton in influenza A infectious cycle]. Tsitologiia (2013) 0.75
[Structure and antiviral activity of adamantane-containing polymer preparation]. Vopr Virusol (2003) 0.75
[The use of the radial hemolysis reaction for demonstrating antibodies to the surface antigens of the influenza virus in assessing postvaccinal immunity]. Mikrobiol Zh (1990) 0.75
[Production of monoclonal antibodies to the human respiratory syncytial virus]. Vestn Ross Akad Med Nauk (1994) 0.75
[Evolutionary variability of influenza B viruses in Russian Federation in 2005-2012]. Vopr Virusol (2013) 0.75
Improved methods of influenza virus propagation. I. Enhancement of virus reproduction in cell cultures. Acta Virol (1977) 0.75
[Usage of polymerase chain reaction in complex diagnosis of hepatitis B]. Vopr Virusol (2000) 0.75
[Development of immunoenzyme assay for subtype-specific detection of antibodies to influenza viruses A (H1N1) and A (H3N2)]. Vopr Virusol (2002) 0.75
[The phenotypic characteristics of healthy carriers of the antigenic structures of the influenza A virus]. Zh Mikrobiol Epidemiol Immunobiol (1996) 0.75
[Development of new approaches to standartization of enzyme immunoassay test systems for detection of antibodies to respiratory syncytial virus using electron microscopy and monoclonal antibodies]. Vopr Virusol (2000) 0.75
Bizarre lymphoid cells in serous effusion of a dog with mediastinal lymphoma. J Comp Pathol (1988) 0.75
[Long-term carriers of genomic structures of the influenza virus in the blood leukocytes of children with congenital pathology of central nervous system]. Vestn Ross Akad Med Nauk (1994) 0.75
[Characteristics of antiviral immunity in children with the atopic form of bronchial asthma]. Pediatriia (1989) 0.75
[The characteristics of the humoral response to respiratory syncytial viral infection in adult patients with different forms of bronchitis]. Vopr Virusol (1992) 0.75
[Influenza: current status and epidemiologic situation]. Vestn Ross Akad Med Nauk (1994) 0.75
[The application of radial hemolysis technique in detection of antibodies to avian influenza virus A (H5N1) and pandemic virus A (H1N1) pdm09]. Klin Lab Diagn (2012) 0.75
[Epitope analysis of the hemagglutinin molecule of the Victoria lineage influenza B viruses]. Vopr Virusol (2014) 0.75
[Arbidole--a new drug for prevention of influenza and acute viral respiratory infections in children]. Vestn Ross Akad Med Nauk (1996) 0.75
[Characteristics of anti-respiratory syncytial humoral immunity during persistence of respiratory syncytial virus antigens in adult patients with chronic obstructive bronchitis]. Vopr Virusol (1996) 0.75
[Comparison of the influenza epidemics in Russia caused by the pandemic virus A(H1N1)pdm09 within the period from 2009 to 2013]. Vopr Virusol (2015) 0.75
Comparative studies on influenza B virus. I. Biological properties and polypeptide composition of strains isolated in different years. Acta Virol (1983) 0.75
Clinico-immunologic and allergologic studies with the inactivated influenza virus vaccine purified and concentrated by gradient centrifugation. Acta Virol (1988) 0.75
[Comparative study of MDCK and CaCo-2 cell lines for influenza virus isolation]. Vopr Virusol (2014) 0.75
CHRONIC HEPATITIS WITH DOUBLE B/C INFECTION: VIROLOGICAL, CLINICAL, MORPHOLOGICAL CHARACTERISTICS. Klin Med (Mosk) (2016) 0.75
[Class I histocompatibility antigens as markers of human susceptibility to influenza A viruses]. Vestn Ross Akad Med Nauk (1995) 0.75
[Development of competitive enzyme immunoassay for the detection of influenza A(H5) virus antibodies]. Klin Lab Diagn (2010) 0.75
[Genetic diversity and molecular evolution of the influenza A viruses in Russia during 2006-2012]. Vopr Virusol (2013) 0.75
[Preparation and characteristics of the antigenic properties of tissue influenza diagnostic agents]. Tr Inst Im Pastera (1982) 0.75
[Clinical and laboratory presentation of the influenza A (H1N1pdm 2009) in children and adults during the period of 2009-2013 in St. Petersburg]. Vopr Virusol (2015) 0.75
[THE APPLICATION OF DOT-TECHNIQUE FOR DETECTING ANTIGENS OF ADENOVIRUS IN CLINICAL SAMPLES]. Klin Lab Diagn (2016) 0.75
[siRNA-mediated inhibition of respiratory syncytial virus replication]. Vopr Virusol (2007) 0.75
[Use of the method of quantitative calculation of fluorescing cells in the study of the periods of absorption and permeability to para-influenza type 2 virus in sensitive cells]. Vopr Virusol (1969) 0.75